Physician

Pramila K. Daftary, M.D.

According to 2025 Medicare claims, Pramila Daftary, M.D. (NPI: 1255399945) practices allergy/immunology in the Waco, TX market, with the plurality of this provider's patient population coming from Mc Lennan, TX. This provider's primary affiliated billing organization is ALLERGY & ASTHMA CARE OF WACO, PA (NPI: 1487847463; TIN: 75-2795625) and primary practice location at 76712-6630.

Daftary's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 367 traditional Medicare patients, billed 18,107 HCPCS/CPT codes, and received $204,358 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 787 prescription claims across 233 beneficiaries totaling $56,336 in drug costs, led by Breztri Aerosphere (Budesonide/Glycopyr/Formoterol). 2020 DME data shows 42 claims. Open Payments data shows 17 records totaling $6,276. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $94,439 to $56,336. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $2,779 to $552.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	338	20,087	$183,085
2016	329	17,874	$165,348
2017	364	20,977	$211,497
2018	335	16,972	$153,063
2019	316	15,690	$144,396
2020	333	14,800	$136,743
2021	337	15,252	$159,341
2022	347	15,828	$176,742
2023	346	15,401	$183,586
2024	367	18,107	$204,358

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	223	1,196	$94,439
2016	238	1,297	$112,800
2017	260	1,490	$105,013
2018	228	1,361	$101,282
2019	247	1,273	$102,536
2020	268	1,282	$133,515
2021	249	763	$69,585
2022	188	529	$56,773
2023	200	740	$64,013
2024	233	787	$56,336

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	29	261	$32,509
2016	14	293	$32,142
2017	N/R	203	$21,181
2018	N/R	178	$19,443
2019	N/R	87	$10,237
2020	N/R	42	$1,566
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	269	545	$89
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	111	155	$13
95165	Professional service for preparation and provision of 1 or more antigens	225	4,858	$10
95117	Professional service for multiple injections of allergen	185	4,528	$8
95004	Test for allergy using allergenic extract	99	5,374	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	23	1,251	$22,902
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	690	$13,949
Montelukast Sodium	Montelukast Sodium	279	14,320	$2,850
Albuterol Sulfate Hfa	Albuterol Sulfate	67	1,374	$1,452
Azelastine Hcl	Azelastine Hcl	62	2,300	$1,386

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$301	Blueprint Medicines Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$5,975	Incyte Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Pramila K. Daftary, M.D.?

Tedicare shows public-source Medicare data for Pramila K. Daftary, M.D. (NPI 1255399945), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pramila K. Daftary, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Pramila K. Daftary, M.D.?

Pramila K. Daftary, M.D. is linked to ALLERGY & ASTHMA CARE OF WACO, PA (billing NPI 1487847463) in the available physician profile data.

Does Pramila K. Daftary, M.D. have Open Payments data?

Pramila K. Daftary, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.